factor-inducible large external (NILE) glycoprotein was selected from a Igtll expression library constructed using mRNA from PC12 cells. A 0.2 kb subclone (pNILE-1B) was used for Northern blot analysis of NILE message present in 2 NILE-positive neuronal cell lines and 2 NILE-negative glial cell lines. pNILE-1 B hybridizes with components of 6.6 and 2.0 kb in the 2 neuronal cell lines but fails to show hybridization with any components in the 2 glial cell lines. Only the 6.6 kb species would be large enough to code for the NILE polypeptide.
A rabbit antiserum was prepared against the NILE-B-galactosidase fusion protein produced by the NILE clone. This antiserum (anti-NILE-&gal) immunoprecipitates NILE glycoprotein from neuronal cell lines, further confirming the authenticity of the NILE cDNA clone. The epitope recognized by anti-NILE-&gal is contained in an 65 kDa tryptic fragment from the phosphorylated carboxy terminus of NILE. The 160 kDa tryptic fragment containing the amino terminus is not recognized by anti-NILE-@-gal. Both immunoprecipitation and immunofluorescence experiments indicate that the anti-NILE+gal epitope is not exposed on the cell surface but is accessible only after cells are treated with detergent. The cytoplasmic nature of the determinant is also indicated by its absence on a truncated, soluble form of NILE released from cells (possibly by a proteolytic mechanism) into the medium. This released NILE is 15-20 kDa smaller than the detergent-extracted NILE and, in addition to lacking the anti-NILE-&gal epitope, does not contain the cytoplasmic site(s) of phosphorylation.
Nucleotide sequencing of the pNILE-1 B subclone confirms the location of the anti-NILE+-gal epitope in the cytoplasmic domain. The clone contains an open reading frame coding for a 79 amino acid segment of the polypeptide that differs in only 2 residues from the cytoplasmic domain of the Ll glycoprotein.
The nerve growth factor-inducible large external (NILE) glycoprotein, first identified as a cell-surface component of PC1 2 cells (McGuire et al., 1978) , has been shown to be present on many types of neuronal cell lines and neurons in primary culture (Salton et al., 1983a, b; Stallcup et al., 1983; Stallcup and Beas-ley, 1985b) . In vivo NILE is expressed on axonal projections in developing nerve fiber tracts of the rat CNS and appears to serve an adhesive function in the fasciculation of axons in the tracts (Stallcup and Beasley, 1985a; Stallcup et al., 1985; Beasley and Stallcup, 1987) . The molecules Ll and Ng-CAM are immunologically and structurally related to NILE (Bock et al., 1985; Friedlander et al., 1986; Sajovic et al., 1986) and serve similar adhesive functions in the mouse and chicken nervous systems, respectively (Grumet et al., 1984b; Rathjen and Schachner, 1984; Keilhauer et al., 1985; Hoffman et al., 1986) . The NILE:Ll:Ng-CAM family of molecules is distinct from the neural cell adhesion molecule (N-CAM) not only structurally (Faissner et al., 1984a; Grumet et al. 1984a; Rathjen and Rutishauser, 1984; Stallcup and Beasley, 1985b) , but also in cellular distribution (Faissner et al., 1984b; Rathjen and Rutishauser, 1984; Rathjen and Schachner, 1984; Thiery et al., 1985; Daniloff et al., 1986; Beasley and Stallcup, 1987) . While N-CAM is widely distributed on multiple neural cell types, both mature and immature, NILE: Ll :Ng-CAM molecules are much more tightly restricted to developing nerve fiber tracts and are thus well suited to serve as specific mediators of adhesion among axons.
In order to understand how the NILE:Ll:Ng-CAM class of glycoproteins function in adhesive interactions, it will be necessary to elucidate the structural characteristics of the molecule, define the organization of its various domains with respect to the cell membrane, and understand how expression of the molecule is controlled during development. Toward these ends we have undertaken molecular cloning of the NILE gene, a project that can ultimately yield both structural data and information about the regulation of expression. In this initial study we describe the isolation of a partial cDNA clone for NILE from a Xgtl 1 expression library and the use of this clone to identify NILE mRNA species in cloned neural cell lines. We also describe the preparation of an antiserum against the NILE-P-galactosidase fusion protein produced by this clone and the characterization of the polypeptide domain recognized by this antiserum.
Materials and Methods
Celllines. For our studies, we used 4 neuronal cell lines-IMR-32 (Tumilowicz et al., 1970) PC 12 (Greene and Tischler, 1976 ) B35 (Schubert et al., 1974) Cl300 cl. N18 (Amano et al., 1972) -and 2 non-neuronal cell lines-B9 and B92 (Schubert et al., 1974) . B9, B92, IMR-32, B35, and Cl 300 cl. N18 were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum. PC12 cells were grown in DMEM containing 10% horse serum and 5% fetal calf serum.
Molecular cloning. A PC12 cDNA library in Xgtl 1 was obtained as a gift from J. Boulter and J. Patrick, the Salk Institute (Boulter et al., 1986) . The ANILE-1 clone described in our work was isolated from the library using immunochemical screening techniques (Huynh et al., 1985) .
Specifically, we used a rabbit antiserum against the Ll glycoprotein (Rathjen and Schachner, 1984) for selecting NILE-positive clones for further purification and study.
For subcloning, ANILE-1 DNA was purified as described by Maniatis et al. (1982) . The phage DNA was digested by Eco RI (BRL) and introduced into the plasmid pGEM-3 blue (Promega Biotec). Two plasmids were obtained from the ANILE-1 clone and designated pNILE-1 A, with a 2.2 kilobase (kb) cDNA insert, and pNILE-lB, with a 0.2 kb cDNA insert.
Northern blot analysis. For the preparation of total cellular RNA from cloned cell lines, cells were harvested and washed with PBS. The cells were pelleted and resuspended in solution containing 4 M guanidinium thiocyanate, 0.5% sodium lauryl sarcosine, 25 mM sodium citrate pH 7.0, 2.4 M cesium chloride, and 0.1 M 2-mercaptoethanol. The RNA was pelleted through a solution of 5.7 M cesium chloride in an ultracentrifuge at 33,000 rpm for 16 hr as described by Maniatis et al. (1982) . The RNA pellet was dissolved in water and twice precipitated with sodium acetate (0.1 M) and ethanol (70%). Poly (A)+ RNA was isolated by chromatography on oligo-d(T) cellulose (Collaborative Research).
Aliquots of poly (A)+ RNA (2.4 &lane) were prepared in 20 mM the immunoreactivity of rabbit antibody against the NILE-fi-galactosidase fusion protein. Some cultures were fixed prior to staining by treatment for 1 hr at 4°C with 1% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. In these experiments 0.1% Triton X-100 was added to the primary antibody to allow permeabilization of the cells. Other cultures were used without fixation and permeabilization so that only cellsurface components were accessible to the antibody. Serum from the preimmune bleed was used as a control in these experiments. Fluorescein-labeled goat antibody against rabbit immunoglobulin (Tago) was used as a second antibody. Incubations with both the primary and secondary antibodies were of 30 min durations and were followed by 4 washes with HEPES-buffered DMEM containing 2% fetal calf serum. The preparations were coverslipped in glycerol containing 0.1 M Tris HCl, pH 8.5, and viewed under epifluorescence with a Nikon Optiphot microscope. Photographs were taken using Kodak Tri-X 400 film:
Radioisotopic labeling and immuneprecipitation. Cell-surface labeling with lzsI (Amersham) was carried out using the lactoperoxidase method (Hubbard and Cohn, 1972) . Metabolic phosphorylation was achieved by growing cells overnight in phosphate-free DMEM containing 200 &/ml dipotassium 32P-phosphate (New England Nuclear). morpholinopropane sulfonic acid, 5 ;M sodium acetate, 1 mM EDTA (1 x MOPS). 50% formamide. and 3% formaldehvde. The samules were heated to 65°C cooled on ice,'and supplemented with gel loading buffer (Maniatis et al., 1982) . The RNA was fractionated on a horizontal 1% agarose-6% formaldehyde gel and stained with acridine orange to permit visualization of the separated components. After electrophoresis, the gel was soaked for 20 min in each of 3 solutions: first, 50 mM NaOH and 0.1 M NaCl. then 0.1 M Tris HCl. oH 7.5. and finallv 20 x SSPE (1 x SSPE = ld mM sodium phosphate, 150 AM NaCl, i mM EDTA, pH 7.4). The RNA was transferred overnight to a nitrocellulose sheet (MSI), which was then baked at 70°C in a vacuum for 2 hr.
Labeled cells were washed 3 times with PBS and extracted with 1% Nonidet P40 (NP40) in PBS. Insoluble material was removed bv centrifugation. The supkrnatants were precleared by incubation with Protein A-Sepharose (Sigma) and then used for immune precipitation. Extracts were incubated with the appropriate rabbit antiserum for 2 hr and then treated with Protein A-Sepharose for an additional 2 hr to isolate immune complexes. The Protein A-Sepharose-immunoglobulin complexes were washed 3 times with PBS containing 0.02% SDS and 0.1% NP40 and boiled in electrophoresis sample buffer (containing 3% SDS and 5% 2-mercaptoethanol) to solubilize the sample.
PAGE and autoradiography. Gradient gels containing 2-20% polyacrylamide were used to analyze most of the immune precipitates. In a few cases, 6% gels were used. The Laemmli (1970) discontinuous buffer system was used in both cases. Stained gels were dried under vacuum, and autoradiograms were prepared using Kodak XAR-5 film and Cronex intensifying screens.
The nitrocellulose sheet was prehybridized overnight at 50°C in a solution of 5 x SSPE, 50% formamide, 1% BSA, 1% Ficoll, 1% polyvinylpyrrolidone, and 200 mg/ml denatured salmon sperm DNA. Hybridization was performed overnight in a fresh solution of the prehybridization solution containing 1 OR cpm of pNILE-1 B, nick-translated with a Boehringer-Mannheim kit. The nitrocellulose sheet was washed 6 times for 30 min each at 68°C in 0.1 x SSPE and 0.1% SDS. An autoradiogram of the dried sheet was prepared using Kodak XAR-5 film at -70°C.
Purification of NILE-fl-galactosidase fusion protein. A lysogen of the NILE-positive clone was produced in E. coliY 1089 (Huynh et al., 1985) . A 5 ml overnight culture of the lysogen was added to 500 ml of LB broth and grown for 3 hr at 32°C with aeration. At this time, the temperature was raised to 42°C by the addition of 500 ml of 1% NaCl solution at 70°C and growth was allowed to continue for 1 hr at 37°C with aeration. Cells were then harvested by centrifugation and lysed by freezing at -70°C. The frozen cell pellet was mixed with 10 ml of 50 mM Tris-HCl, 150 mM NaCl, pH 8.0 (Tris-saline), containing 1 mM EDTA, 0.3 mM PMSF, 1 mM benzamidine, 10 r&ml soybean trypsin inhibitor, and 10 r&ml DNase I. Particulate cell debris was removed by centrifugation, and the supematant was gently shaken overnight at 4°C with Sepharose 4B beads derivatized with monoclonal antibody against P-galactosidase. Following the incubation period, the beads were poured into a column and washed thoroughly with T&-saline. Material bound to the column was eluted with Tris-saline buffer containing 8 M urea. Eluted material was dialyzed extensively against 10 mM ammonium acetate, pH 7.0, and lyophilized to dryness. SDS-PAGE of this material revealed a major 150 kDa component that was recognized both by rabbit anti-&galactosidase (Cappel) and by rabbit anti-L1 antibody on Western blots (Towbin et al., 1979) .
DNA sequencing. Sequence analysis by the dideoxynucleotide method was performed using a Promega Biotec IVRT kit and dATP (@S) from New England Nuclear. Reaction products were analyzed by electrophoresis in a BioRad Geneseq apparatus, followed by autoradiography with Kodak XAR-5 film.
Results

Identtfication
of NILE mRNA and partial sequence of the encoded polypeptide Antisera. Rabbit antiserum against the NILE glycoprotein has been described previously (Stallcup and Beasley, 1985a; Stallcup et al., 1985) . Rabbit antibody against Ll glycoprotein was a generous gift from Dr. Melitta Schachner, University of Heidelberg. Monoclonal antibody against ,&galactosidase was provided by Dr. Larry Rohrschneider, Hutchinson Cancer Center. Rabbit antibody against the NILE-p-galactosidase fusion protein was produced by an initial subcutaneous injection of the purified fusion protein in complete Freund's adjuvant. Two booster immunizations were given on days 14 and 24 with fusion protein emulsified in incomplete Freund's adjuvant. Bleeds were taken on days 20, 34, and 37. A preimmune bleed from the same rabbit was used as a control in the immunoprecipitation experiments.
We used rabbit antibody against Ll to select a NILE-positive clone @NILE-1) from a Xgt 11 expression library prepared using mRNA from PC1 2 cells. The 2.4 kb ANILE-1 cDNA insert was subcloned into plasmids as 2 Eco RI fragments-the 2.2 kb pNILE-1A and the 0.2 kb pNILE-1 B. The pNILE-1 B subclone was used as a probe for Northern blot analysis of NILE mRNA species present in several neural cell lines that had previously been characterized for the presence or absence of NILE (Stallcup et al., 1983) . Figure 1 shows that the probe does not recognize any mRNA componenfs from 2 NILE-negative cell lines, B9 and B92. In contrast, hybridizing messages of about 2.0 and 6.8 kb are seen in the poly (A)+ RNA from 2 NILE-positive cell lines, PC12 and B35. The nucleotide sequence of the pNILE-1 B clone is shown in Figure 2 along with the amino acid sequence deduced from the only open reading frame in this segment of cDNA. The corresponding sequences for the Ll glycoprotein (Moos et al., 1988) are shown for comparison. The 2 sequences differ in only 11 nucleotides and 2 amino acids.
Recognition of NILE by antibody against putative NILE-Pgalactosidase fusion protein
ImmunojZuorescence. Cultures of postnatal day 6 rat cerebellum were On Western blots, a 150 kDa polypeptide from the ANILE-1 prepared as described previously (Stallcup et al., 1983 ) and used to test clone was recognized by both anti-L1 and anti-p-galactosidase Fiacre 1. Northern blot analysis of -0 NILE mRNA. Poly (A)+ RNA,-2.4 pg from each of several neural cell lines, was fractionated on a 1% agaroseformaldehyde gel and transferred to nitrocellulose. The Northern blot was probed with the pNILE-1B cDNA as described in Materials and Methods. The 2 neuronal cell lines PC1 2 and B35 have hybridizing species of about 2.0 and 6.8 kb, while the 2 non-neuronal cell lines lack hybridizing components. The sizes of RNA standards are given on the right-hand side in kilobases.
PC12 B9 B35 B92
antibodies. This putative NILE-p-galactosidase fusion protein was purified by immunoaffinity chromatography on anti-ggalactosidase-Sepharose 4B and used to immunize a rabbit.
We assessed the reactivity of the anti-fusion protein antibody (anti-NILE-&gal) in a series of immune precipitation experiments. Three neuronal cell lines-PC12 (rat), B35 (rat), and C 1300 cl. N 18 (mouse)-were used as the primary sources of NILE for this analysis, and the results reported here were con-.firmed with each of the 3 cell lines. The figures do not show the data for all 3 cell lines in every case, but instead provide selected examples of the results with the different cell lines to illustrate the generality of the findings. A human neuroblastoma, IMR-32, was used in a few cases. The cell lines were labeled with 12*1 and extracted with NP40, and the extracts were treated with anti-NILE-P-gal. Parallel samples were treated with preimmune serum and with rabbit anti-NILE antibodies. Figure 3 shows that preimmune serum does not recognize L251-labeled components in these extracts, but that the anti-NILE and anti-NILE-,&gal antibodies both recognize identical NILE species from each of the 3 cell lines shown. The relative effectiveness of the 2 antisera in recognizing the various forms of NILE is reproducible. They are approximately equal in their ability to immunoprecipitate PC12 NILE, but anti-NILE is more effective with B35 NILE, while anti-NILE-&gal is more effective with N18 NILE. This suggests that there may be differences in the structure of NILE from the different cell lines. In the case of the human cell line IMR-32, anti-NILE-P-gal recognizes a NILElike molecule of 200 kDa that is not recognized by anti-NILE (not shown). Thus, anti-NILE-&gal may recognize an epitope that is more highly conserved across species than the epitopes recognized by anti-NILE.
The difference in molecular weights of the NILE molecules from these different cell types has already been noted (Stallcup et al., 1983; Stallcup and Beasley, 1985b) . The fact that the component recognized by anti-NILE-@-gal varies in size in exactly the same way as the component recognized by anti-NILE reinforces the conclusion that anti-NILE-P-gal does, in fact, react with NILE. Further verification of this is provided in lys arg ser lys gly gly lys tyr ser val lys asp lys lys glu asp thr gln AAA CGC AGC AAG GGT GGC AAA TAC TCA GTG AAG GAC AAG AAG GAG GAC ACT GAG --G GAG GAC ACT GAG ---glu asp thr gln val asp ser glu ala arg pro met lys asp glu thr phe gly glu tyr arg ser GTA GAT TCC GAG GCC CGG CCC ATG AAA GAC GAG ACC TTC GGC GAG TAC AGG TCC GTA GAT TCC GAG GCC CGG CCC ATG AAA GAC GAG ACC TTC GGC GAG TAC AGG TCC val asp ser glu ala arg pro met lys asp glu thr phe gly glu tyr arg ser leu glu ser asp asn glu glu lys ala phe gly ser ser gln pro ser leu asn CTG GAG AGT GAC AAT GAA GAG AAG GCC T CTG GAG AGT GAC AAT GAA GAG AAG GCC T 8 GGC AGC AGC CAG CCA TCT CTC A GGC AGC AGC CAG CCA TCT CTC A 8 leu glu ser asp asn glu glu lys ala phe gly ser ser gln pro ser leu asn glY ile lys pro leu gly ser asp asp ser leu ala asp tyr gly gly ser GGA GAE ATC AAA CCC CTA CGC AGT GAT GAC A CTG GCT GAT TAT GGG GGC AGT GGA GGC ATC AAA CCC CTA GGC AGT GAT GAC A . Neuraminidase treatment and trypsin treatment of B35 cells produce anti-NILE-reactive species that migrate more rapidly than intact NILE. In each case, anti-NILE-P-gal recognizes components indistinguishable from those recognized by anti-NILE.
Location of the epitope recognized by anti-NILE+gal Faissner et al. (1985) have shown that the 200 kDa Ll molecule can be cleaved by mild trypsin treatment into fragments of 80 and 140 kDa, neither of which is released from the cell by the trypsinization procedure. After treatment of lZ51-labeled PC 12 cells with 10 &ml trypsin for 15 min at room temperature and subsequent NP40 extraction of the trypsinized cells, we can show that anti-NILE-@-gal immunoprecipitates both a 160 and an 85 kDa component (Fig. 4A) . The 85 kDa component is phosphorylated, while the 160 kDa component is not (data not shown), suggesting that these 2 fragments from the 230 kDa NILE molecule correspond to the 80 and 140 kDa fragments 116:
92:
NPFNPFNPF PC12 635 N18 Figure 3 . Recognition of NILE by anti-NILE-&gal and anti-NILE. Three neuronal cell lines (PC12, B35, and N18) were labeled with 125I and extracted with NP40 as described in Materials and Methods. Aliquots containing equal numbers of cpm were subjected to immune precipitation using 3 different sera: anti-NILE(N), preimmune serum (P), and anti-NILE-&al fusion protein (F). The immunoprecipitates were analyzed by SDS-PAGE using a 2-20% gradient gel. Note that, although the NILE species from the 3 cell lines vary in apparent molecular weight, the anti-NILE and anti-NILE-p-gal reagents recognize the same component in each case. The preimmune serum is negative in each case. The various extracts were then incubated with 10 ~1 of antibody against the NILE-@-gal fusion protein (F') or with 10 ~1 of preimmune serum (P). Protein A-Sepharose was used to complete the immune precipitation, and immune precipitates were analyzed on 2-20% SDS-polyacrylamide gradient gels. Anti-NILE+gal recognizes intact NILE (230 kDa) before and after treatment with SDS. Anti-NILE-@-gal immunoprecipitates both the 160 and 85 kDa tryptic fragments of NILE prior to treatment with SDS but recognizes only the 85 kDa fragment after SDS treatment. B, Disulfide bonding. 12SI-labeled PC12 cells were left untreated or treated with 10 &ml trypsin for 15 min at room temperature. Extracts of both samples were made with 1% NP40, and immunoprecipitates were prepared using 10 ~1 of antibody against NILE-@-gal fusion protein (F) or 10 jd of preimmune serum (P). Immune precipitates were dissolved by boiling in nonreducing (non) electrophoresis sample buffer or in reducing (red) sample buffer containing 5% 2-mercaptoethanol.
Electrophoretie analysis was made on 6% SDSpolyacrylamide gels. The 160 and 85 kDa tryptic fragments are not linked by disulfide bonds, since they migrate separately under both reducing and nonreducing conditions. However, the 160 kDa fragment appears to contain disulfide bonds that cause the fragment to migrate as a more compact entity under nonreducing conditions. A similar effect is seen with the intact NILE molecule. of Ll (see Faissner et al., 1985; Sadoul et al., 1988) . In the likely that anti-NILE-P-gal could recognize determinants on both absence of detergent there is very little release of either fragment ends of the NILE molecule, the ability of the antibody to imfrom PC 12 cells during the trypsinization period (see below for munoprecipitate both fragments is puzzling. This behavior can a discussion of longer time periods). be explained, however, if the 2 fragments still associate tightly Since the limited amount of NILE polypeptide present in the after proteolytic clipping. One means of maintaining such an NILE-&galactosidase fusion protein makes it extremely unassociation is disulfide bonding between the 2 fragments. If this is the case, electrophoresis of trypsin-treated NILE under nonreducing conditions should reveal a species with a mobility similar to that of the intact NILE molecule. Figure 4B shows that this is not the case. Typsinized NILE under nonreducing conditions still migrates as 2 nonlinked fragments. The fact that the larger of the 2 fragments migrates more rapidly under nonreducing conditions than under reducing conditions strongly suggests, however, that disulfide bonding plays a role in stabilizing the conformation of this portion of the molecule. Nonreducing conditions also produce a shift in mobility of the intact NILE molecule. Apparently, noncovalent forces are responsible for the tight association of the 2 NILE fragments (Sadoul et al., 1988) . If the NP40 extracts of 1251-labeled, trypsinized PC1 2 cells are boiled with 0.2% SDS prior to immune precipitation, these noncovalent interactions are disrupted and only the 85 kDa fragment is immunoprecipitated by anti-NILE-&gal (Fig. 4A) . A control experiment shows that the intact 230 kDa NILE molecule is recognized by anti-NILE-P-gal after the SDS treatment.
In the foregoing experiments, the cells were always extracted with detergent prior to the addition of antibodies. In another set of experiments, intact 1251-labeled cells were treated with anti-NILE and anti-NILE-P-gal for 1 hr and then washed free of unbound antibody before being extracted with NP40. In this way only determinants exposed on the cell surface could be recognized by the antibodies. Figure 5 shows that although both antibody preparations recognize NILE after it has been extracted from PC 12 and N 18 cells, only anti-NILE is able to recognize NILE exposed on the surface of intact cells. The epitope recognized by anti-NILE-P-gal is apparently not exposed on the cell surface. This result is supported by immunofluorescence experiments with anti-NILE-P-gal (Fig. 6) . The antibody does not stain living cerebellar neurons in culture, showing that the epitope recognized by the antibody is not exposed on the cell surface (a and b). However, if the cultures are fixed and permeabilized to allow access to intracellular structures, the anti-NILE-P-gal antibody stains both the cell bodies and processes of neurons (c and d). Preimmune serum also stains neuronal cell bodies in the fixed; permeabilized cultures (e and j), suggesting that this portion of the labeling is nonspecific or at least irrelevant to the NILE-P-galactosidase epitope. Thus, the epitope recognized by the anti-NILE-@-gal antibody is an intracellular one and is localized to net&es. The preferential staining of neuronal processes, as opposed to cell bodies, has been reported to be characteristic of anti-NILE antibodies (Stallcup et al., 1983 (Stallcup et al., , 1985 Stallcup and Beasley, 1985a) .
It has been noted previously that a slightly truncated form of the NILE molecule is slowly released or secreted over a period of hours from the surface of neuronal cells even in the absence of detergent (Salton et al., 1983b , Sweadner, 1983 RichterLandsberg et al., 1984; Stallcup and Beasley, 1985b) . The mechanism of the spontaneous release is not well understood, but it is most often attributed to proteolytic clipping of the molecule (Sweadner, 1983; Richter-Landsberg et al., 1984; Stallcup and Beasley, 1985b) . Figure 7 compares the secreted and detergentextracted forms of NILE derived from control B35 cells, neuraminidase-treated B35 cells, and trypsin-treated B35 cells. It is apparent that anti-NILE-&gal does not recognize the secreted form of NILE. This same phenomenon is observed in the case of PC 12 and N 18 cells (data not shown). Thus, secreted NILE must lack a determinant that is present on the extracted form of NILE. It seems likely that the determinant in question is 200, 116, 92, 67, xsxsxsxs N F N F PC12 N18 Figure 5 . Exposure of NILE determinants on the cell surface. PC12 cells and N 18 cells were labeled with 1251. One aliquot of each cell line was extracted with NP40 (x) and the extract used for immune precipitation with anti-NILE (iV) and anti-NILE-&gal (0. Other aliquots of each cell line were treated with the same 2 antibodies prior to extraction with NP40, so that only determinants exposed on the cell surface (s) could be recognized. After a 1 hr incubation with antibodies, these cells were washed 3 times with PBS to remove unbound antibody. NP40 extracts were then prepared and treated with Protein A-Sepharose to isolate the immune precipitates. Precipitates were analyzed on a 2-20% gradient gel. Whereas anti-NILE recognizes NILE both in the detergent extracts and exposed on the surface of intact cells, anti-NILE-@-gal does not recognize NILE determinants exposed on the cell surface. The determinant recognized by this antibody is exposed only after detergent extraction.
located in the 15 kDa of material that is missing from released NILE. Two experiments indicate that this 15 kDa is lost from the phosphorylated domain of the molecule. First, the truncated, secreted form of NILE immunoprecipitated by anti-NILE'is not labeled with 32P, indicating that the phosphorylated portion of the molecule (like the anti-NILE-P-gal determinant) is lost during the release process (data not shown). Second, the 160 kDa tryptic fragment found in the secreted material is indistinguishable from its detergent-extracted counterpart, suggesting that this domain of the molecule is unaffected by secretion and that the proteolytic event must occur in the 85 kDa domain (Fig. 7) .
Discussion
The cDNA clone ANILE-1 was selected from a Xgt 11 library on the basis of its reactivity with antibody against the Ll glycoprotein. ANILE-1 has a cDNA insert of 2.4 kb that was subcloned into plasmids in the form of 2 distinct Eco RI fragments. The smaller of the 2 subclones, pNILE-1 B with a 0.2 kb cDNA insert, was used as a probe to identify mRNA for NILE. The sources of RNA for these experiments were 4 cloned neural cell lines that had previously been tested for expression of NILE glycoprotein (Stallcup et al., 1983) . The 2 non-neuronal, NILEnegative cell lines (B9 and B92) did not have RNA species capable of hybridizing with the pNILE-1B probe, while the 2 neuronal, NILE-positive cell lines (B35 and PC12) each had RNA components of about 2.0 and 6.8 kb that hybridized with correspond to the 140 and 80 kDa fragments produced by mild trypsinization of the smaller Ll glycoprotein . As shown by Sadoul et al. (1988) , in NP40 extracts the 2 fragments do not dissociate from each other, and thus both are immunoprecipitated by anti-NILE-&gal. The tight association of the fragments is not mediated by disulfide bonding, but instead by noncovalent interactions that can be disrupted by boiling the NP40 extract with 0.2% SDS. Under these conditions, anti-NILE-P-gal immunoprecipitates only the 85 kDa fragment. It is worth noting that, although there is no disulfide bonding between the 2 fragments, the conformation of the 160 kDa fragment appears to be stabilized by disulfide bonds. This is consistent with the evidence of Moos et al. (1988) that the extracellular domain of Ll contains immunoglobulin-like, disulfide-bonded domains.
Having established that the antigenic determinant recognized by anti-NILE-P-gal is found in the 85 kDa fragment, we can further pinpoint its location within this portion of NILE. Work in other laboratories has established that this region of the molecule contains a phosphorylated cytoplasmic domain (Salton et al., 1983b; Faissner et al., 1985; Sadoul et al., 1988) . Our experiments indicate that the anti-NILE-&gal determinant is located in this cytoplasmic domain. First, both immunoprecipitation and immunofluorescence experiments show that this determinant is not exposed on the surface of intact cells but is recognized only after cells are treated with detergent. The "buried" nature of the determinant is consistent with its being located in a cytoplasmic domain. Second, the slightly truncated, spontaneously released form of NILE contains neither the antigenic determinant nor the phosphorylated residue(s). This is compatible with the idea that the "secretion" phenomenon is associated with a proteolytic event that releases most of the molecule from the cell surface, leaving behind a small membrane-bound domain containing the anti-NILE-&gal determinant. Although it is highly speculative in the absence of additional sequence information for the extracellular portion of NILE, it is possible that the cytoplasmic portion may be more highly conserved than other parts of the molecule. The anti-NILE-Pgal antibody, which recognizes cytoplasmic determinants, immunoprecipitates not only rodent NILE, but also human NILE. In contrast, the anti-NILE antibody used in our experiments recognizes extracellular determinants of NILE and fails to immunoprecipitate the molecule from the human cell line IMR-32. These extracellular determinants of NILE thus appear to be less highly conserved than the cytoplasmic determinant, which, as we have seen in Figure 2 , is virtually identical in mouse and rat. An unusually high degree of sequence conservation has previously been observed in the cytoplasmic domains of the T200 glycoprotein (Thomas et al., 1985; Ralph et al., 1987; Raschke, 1987) and the p-subunit of the fibronectin receptor (Tamkun et al., 1986; Argraves et al., 1987) . This would suggest an important function for the cytoplasmic portion of these transmembrane molecules, possibly in mediating interactions with the cytoskeleton.
The spontaneous release of NILE from the cell surface may be peculiar to cloned cell lines, since it is not observed with neurons in primary culture. However, release of NILE can be induced in primary cultures under certain conditions (Sweadner, 1983; Sadoul et al., 1988) producing the same type of soluble, truncated NILE described in our results. If a proteolytic event is indeed responsible for this "secretion" of NILE, it may be that cell lines have unusually high levels of the necessary proteolytic enzyme.
A simple model, patterned after that proposed for Ll by Sadoul et al. (1988) , can be used to illustrate the major structural features of NILE (Fig. 8) . The data from Schachner's laboratory indicate that the shorter, phosphorylated tryptic fragment of Ll represents the carboxy terminus of the molecule, while the larger, nonphosphorylated fragment contains the amino terminus (see Faissner et al., 1985; Moos et al., 1988) . The site of trypsin cleavage is indicated by the arrow, splitting NILE into fragments of 160 and 85 kDa. The closed loop in the polypeptide represents the site of strong, noncovalent interaction between the 2 domains, while the 2 open loops in the 160 kDa domain are shown to be stabilized by disulfide bonds. The number of disulfides chosen is purely arbitrary and is not based on experimental determination. The Ll glycoprotein appears to have 6 such disulfide-bonded domains (Moos et al., 1988) . The arrowhead identifies the hypothetical site of proteolysis, which leads to spontaneous release of truncated, soluble NILE from the cell surface. Our nucleotide sequence data show that NILE-1 B codes for the carboxy terminal region of NILE. In agreement with this, our immunochemical evidence indicates that the epitope recognized by anti-NILE-P-gal must be located within the cytoplasmic domain at the carboxy terminal end of the molecule. This domain is not exposed on the cell surface and is left behind during the "secretion" of soluble NILE.
